Evaluation of recurring cytogenetic abnormalities in the treatment of myelodysplastic syndromes
- 30 April 2007
- journal article
- review article
- Published by Elsevier in Leukemia Research
- Vol. 31 (4) , 427-434
- https://doi.org/10.1016/j.leukres.2006.10.023
Abstract
No abstract availableKeywords
This publication has 60 references indexed in Scilit:
- Cytogenetic aspects of adult primary myelodysplastic syndromes: Clinical implicationsCancer Letters, 2006
- Clinical features of prognostic significance in myelodysplastic patients with normal karyotype at high risk of transformationLeukemia Research, 2005
- The Hematopoietic Stem Cell in MyelodysplasiaThe International Journal of Cell Cloning, 2004
- Myelodysplastic syndromes: from pathogenesis and prognosis to treatmentSeminars in Hematology, 2004
- Myelodysplastic syndromesThe Hematology Journal, 2004
- Cytogenetics in acute leukemiaBlood Reviews, 2003
- Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001Leukemia, 2002
- The cytogenetics of myelodysplastic syndromesBest Practice & Research Clinical Haematology, 2001
- Cytogenetic findings in primary and secondary MDSLeukemia Research, 1992
- Chromosome aberrations and prognostic factors in therapy-related myelodysplasia and acute nonlymphocytic leukemiaBlood, 1990